Cogent Biosciences, Inc. COGT Issuance of stock under employee stock plans

Issuance of stock under employee stock plans at other companies

Lumentum Holdings Inc.LITE

$500K+150%

Wintrust FinancialWTFC

$1.91M+4.7%

CloroxCLX

-$2M-300%

ServiceNowNOW

$153M0.0%

BlockXYZ

$618K-72.9%

Moody'sMCO

$13M-43.5%

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s issuance of stock under employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s issuance of stock under employee stock plans?: Cogent Biosciences, Inc. (COGT) reported issuance of stock under employee stock plans of $1.06M in Q1 2026.
How has Cogent Biosciences, Inc.'s issuance of stock under employee stock plans changed year-over-year?: Cogent Biosciences, Inc.'s issuance of stock under employee stock plans increased by 81.8% year-over-year, from $584K to $1.06M.